Real-World Applications of Clinical Trial Data and Changing Guidelines in IBD

Real-World Applications of Clinical Trial Data and Changing Guidelines in IBD is organized by Prime Education, LLC.

Dates: 
Release Date: December 06, 2019
Expiration Date: December 06, 2020

Accreditation:
• 1.0 CME/CE for Physicians (ACCME)
• 1.0 CME/CE for Physician Assistants (AAPA)
• 1.0 CME/CE for Nurse Practitioners (AANP)
• 1.0 CPE for Pharmacists (ACPE + NABP)
• 1.0 CNE for Nurses (ANCC)
• 1.0 CE for Case Managers (CCM, pre-approved)

Activity Overview:
Experts from across the aisle come together to discuss how the latest evidence—including hot-off-the-press data from the ACG and UEG meetings - and newly updated guidelines are shaping current approaches to the treatment and management of inflammatory bowel disease (IBD).

Case-based discussions center on the application of evidence to overcome challenges faced in the assessment, treatment, and management of moderate to severe disease and to ensure that patients achieve the highest levels of treat-to-target outcomes in IBD.

Learning Objectives:
• Align managed care and specialty pharmacy strategies with evidence-based IBD guidelines and treat-to-target approaches for achieving evolving treatment goals, including mucosal healing and steroid-free remission
• Apply recent research on the comparative effectiveness of biologics to therapy selection for patients with IBD
• Improve alignment of treatment practice patterns with evidence-based FL guidelines
• Develop managed care and specialty pharmacy frameworks that account for evolving therapeutic mechanisms and routes of administration in IBD

Additional details will be posted as soon as information is available.